中证网讯(记者 郭(guo)霁(ji)莹(ying))记者从国药集(ji)团8月(yue)15日举办的媒体通气会上获悉,在8月(yue)3日发(fa)布(bu)的《财富》世(shi)界500强(qiang)企业(ye)榜单(dan)中,国药集(ji)团位(wei)(wei)列第80位(wei)(wei),首次迈进百强(qiang)榜单(dan)。
“从(cong)2013年(nian)(nian)首次(ci)入围《财富(fu)》杂志世界500强排行榜,到2022年(nian)(nian)挺进百(bai)强,国(guo)药(yao)集(ji)团(tuan)排名连续十(shi)年(nian)(nian)上升。”国(guo)药(yao)集(ji)团(tuan)副总(zong)经(jing)理胡建伟表示,国(guo)药(yao)集(ji)团(tuan)在这十(shi)年(nian)(nian)里深化国(guo)企(qi)改(gai)革,战略性重(zhong)组和(he)专业(ye)(ye)化整合取得积极进展。十(shi)年(nian)(nian)来,国(guo)药(yao)集(ji)团(tuan)营业(ye)(ye)收(shou)入从(cong)2046亿元(yuan)增至7017亿元(yuan),资(zi)产总(zong)额(e)从(cong)1683亿元(yuan)增长到5640亿元(yuan)。2021年(nian)(nian),国(guo)药(yao)集(ji)团(tuan)利润总(zong)额(e)突破千亿,净(jing)资(zi)产收(shou)益率和(he)国(guo)有资(zi)产保值增值率位(wei)列中央企(qi)业(ye)(ye)第一位(wei),连续9个年(nian)(nian)度和(he)3个任(ren)期获评(ping)中央企(qi)业(ye)(ye)经(jing)营业(ye)(ye)绩(ji)考核A级。
国(guo)药(yao)(yao)集团在中(zhong)(zhong)药(yao)(yao)板块(kuai)方面(mian)表现亮眼。国(guo)药(yao)(yao)中(zhong)(zhong)药(yao)(yao)总经理、中(zhong)(zhong)药(yao)(yao)控(kong)股(gu)董事(shi)长陈映龙介绍,目前国(guo)药(yao)(yao)集团中(zhong)(zhong)药(yao)(yao)板块(kuai)中(zhong)(zhong)药(yao)(yao)配方颗(ke)粒科研技术(shu)生(sheng)产能(neng)(neng)力、市场规(gui)模(mo)(mo)居于(yu)全(quan)国(guo)第一(yi),中(zhong)(zhong)药(yao)(yao)材基地(di)布(bu)局和产地(di)初加工能(neng)(neng)力位(wei)列全(quan)国(guo)第一(yi),中(zhong)(zhong)药(yao)(yao)饮片共享(xiang)中(zhong)(zhong)药(yao)(yao)智能(neng)(neng)配送中(zhong)(zhong)心模(mo)(mo)式为全(quan)国(guo)第一(yi),中(zhong)(zhong)成药(yao)(yao)品种数(shu)量(liang)和生(sheng)产能(neng)(neng)力位(wei)居全(quan)国(guo)第一(yi),生(sheng)产质(zhi)(zhi)量(liang)、控(kong)制标准和可追溯(su)质(zhi)(zhi)量(liang)保障体系全(quan)国(guo)领(ling)先。
2012年(nian)至2021年(nian),国药(yao)集(ji)团现(xian)(xian)代中药(yao)板块经营效(xiao)益大幅(fu)提升(sheng)。截至2021年(nian)底,国药(yao)集(ji)团现(xian)(xian)代中药(yao)板块资产规模达(da)到546.05亿元,实现(xian)(xian)营业(ye)收入327.55亿元,净利润(run)20.69亿元。
与此同时,国(guo)药(yao)集团坚持拓展中(zhong)(zhong)(zhong)药(yao)产业链覆盖(gai)(gai)的(de)广(guang)度与深(shen)度,强(qiang)(qiang)化完善药(yao)品全(quan)(quan)生(sheng)命周期管理。一(yi)方(fang)(fang)面,提升(sheng)中(zhong)(zhong)(zhong)药(yao)材生(sheng)产水平。深(shen)入(ru)道地产区,强(qiang)(qiang)化种(zhong)(zhong)子种(zhong)(zhong)苗良种(zhong)(zhong)繁育研究,为产业链下游(you)提供有质量保(bao)障(zhang)的(de)药(yao)材种(zhong)(zhong)子,并强(qiang)(qiang)化规(gui)范化生(sheng)产与经营。国(guo)药(yao)集团现代中(zhong)(zhong)(zhong)药(yao)板(ban)(ban)块(kuai)自2019年起累计(ji)建设中(zhong)(zhong)(zhong)药(yao)材GACP基地200多个(ge),覆盖(gai)(gai)80多个(ge)品种(zhong)(zhong),种(zhong)(zhong)植面积逾30万亩(mu)。另(ling)一(yi)方(fang)(fang)面,加(jia)快中(zhong)(zhong)(zhong)药(yao)工业转(zhuan)型(xing)升(sheng)级(ji)。国(guo)药(yao)集团旗下的(de)一(yi)方(fang)(fang)制药(yao)、天江药(yao)业占国(guo)内中(zhong)(zhong)(zhong)药(yao)配方(fang)(fang)颗(ke)粒超过(guo)52%的(de)市场份额。中(zhong)(zhong)(zhong)药(yao)饮片板(ban)(ban)块(kuai)业务覆盖(gai)(gai)全(quan)(quan)国(guo)重点(dian)城市。中(zhong)(zhong)(zhong)成药(yao)板(ban)(ban)块(kuai)整合了(le)中(zhong)(zhong)(zhong)药(yao)控(kong)股和(he)国(guo)药(yao)太极(ji)两(liang)大产品线,拥有包(bao)括藿香正气液、急支(zhi)糖浆、玉屏风化湿败毒颗(ke)粒等(deng)超过(guo)1500个(ge)成药(yao)品规(gui)。国(guo)药(yao)集团还积极(ji)发展中(zhong)(zhong)(zhong)医(yi)药(yao)健康(kang)服务业,在(zai)多个(ge)省市落地国(guo)医(yi)馆(guan),提供多元化中(zhong)(zhong)(zhong)医(yi)药(yao)健康(kang)服务。
中证网讯(记(ji)者 郭霁莹)记(ji)者从国药(yao)集(ji)团8月15日举办的媒体通气会上获(huo)悉,在8月3日发布的《财(cai)富》世界(jie)500强企(qi)业(ye)榜单(dan)中,国药(yao)集(ji)团位列第80位,首次迈进百强榜单(dan)。
“从2013年(nian)(nian)(nian)(nian)首次入围《财(cai)富》杂志世界500强排(pai)行榜,到(dao)2022年(nian)(nian)(nian)(nian)挺(ting)进百强,国(guo)(guo)(guo)药(yao)集(ji)(ji)团(tuan)(tuan)排(pai)名连续十(shi)年(nian)(nian)(nian)(nian)上(shang)升(sheng)。”国(guo)(guo)(guo)药(yao)集(ji)(ji)团(tuan)(tuan)副(fu)总经(jing)理胡建伟表示,国(guo)(guo)(guo)药(yao)集(ji)(ji)团(tuan)(tuan)在这十(shi)年(nian)(nian)(nian)(nian)里(li)深化国(guo)(guo)(guo)企(qi)改革,战略性重(zhong)组(zu)和专业(ye)(ye)(ye)化整合取得积极进展。十(shi)年(nian)(nian)(nian)(nian)来(lai),国(guo)(guo)(guo)药(yao)集(ji)(ji)团(tuan)(tuan)营(ying)业(ye)(ye)(ye)收(shou)入从2046亿(yi)元(yuan)(yuan)增(zeng)至7017亿(yi)元(yuan)(yuan),资(zi)产总额从1683亿(yi)元(yuan)(yuan)增(zeng)长到(dao)5640亿(yi)元(yuan)(yuan)。2021年(nian)(nian)(nian)(nian),国(guo)(guo)(guo)药(yao)集(ji)(ji)团(tuan)(tuan)利润总额突破千亿(yi),净(jing)资(zi)产收(shou)益率和国(guo)(guo)(guo)有(you)资(zi)产保值增(zeng)值率位(wei)列中央企(qi)业(ye)(ye)(ye)第(di)一位(wei),连续9个年(nian)(nian)(nian)(nian)度和3个任期(qi)获评(ping)中央企(qi)业(ye)(ye)(ye)经(jing)营(ying)业(ye)(ye)(ye)绩考核A级。
国(guo)药(yao)(yao)(yao)集(ji)团(tuan)在中(zhong)(zhong)药(yao)(yao)(yao)板(ban)块方面表(biao)现亮眼。国(guo)药(yao)(yao)(yao)中(zhong)(zhong)药(yao)(yao)(yao)总经理、中(zhong)(zhong)药(yao)(yao)(yao)控(kong)股董事长陈映(ying)龙介(jie)绍,目前国(guo)药(yao)(yao)(yao)集(ji)团(tuan)中(zhong)(zhong)药(yao)(yao)(yao)板(ban)块中(zhong)(zhong)药(yao)(yao)(yao)配方颗(ke)粒科研技术生产(chan)能(neng)(neng)力、市场规模居于(yu)全(quan)国(guo)第(di)一(yi),中(zhong)(zhong)药(yao)(yao)(yao)材(cai)基地布局和产(chan)地初加工能(neng)(neng)力位(wei)列全(quan)国(guo)第(di)一(yi),中(zhong)(zhong)药(yao)(yao)(yao)饮(yin)片(pian)共享(xiang)中(zhong)(zhong)药(yao)(yao)(yao)智能(neng)(neng)配送中(zhong)(zhong)心模式为(wei)全(quan)国(guo)第(di)一(yi),中(zhong)(zhong)成药(yao)(yao)(yao)品种(zhong)数量和生产(chan)能(neng)(neng)力位(wei)居全(quan)国(guo)第(di)一(yi),生产(chan)质量、控(kong)制标准和可追溯(su)质量保障体(ti)系全(quan)国(guo)领先。
2012年(nian)至(zhi)2021年(nian),国药(yao)(yao)集团现代(dai)中(zhong)药(yao)(yao)板(ban)块(kuai)经营效益大幅(fu)提升(sheng)。截至(zhi)2021年(nian)底,国药(yao)(yao)集团现代(dai)中(zhong)药(yao)(yao)板(ban)块(kuai)资产规模达到(dao)546.05亿(yi)元,实现营业收入327.55亿(yi)元,净(jing)利润(run)20.69亿(yi)元。
与(yu)(yu)此同时,国(guo)药(yao)(yao)(yao)集团坚(jian)持拓展(zhan)中(zhong)(zhong)(zhong)药(yao)(yao)(yao)产(chan)业(ye)链覆(fu)盖的(de)(de)(de)广度(du)与(yu)(yu)深度(du),强(qiang)(qiang)化(hua)(hua)(hua)(hua)完(wan)善药(yao)(yao)(yao)品全(quan)生命周期管理(li)。一方(fang)面(mian),提(ti)(ti)升(sheng)中(zhong)(zhong)(zhong)药(yao)(yao)(yao)材生产(chan)水平(ping)。深入道地产(chan)区,强(qiang)(qiang)化(hua)(hua)(hua)(hua)种(zhong)子(zi)种(zhong)苗(miao)良(liang)种(zhong)繁育研究(jiu),为产(chan)业(ye)链下游提(ti)(ti)供有质量保(bao)障的(de)(de)(de)药(yao)(yao)(yao)材种(zhong)子(zi),并强(qiang)(qiang)化(hua)(hua)(hua)(hua)规(gui)范(fan)化(hua)(hua)(hua)(hua)生产(chan)与(yu)(yu)经营。国(guo)药(yao)(yao)(yao)集团现代中(zhong)(zhong)(zhong)药(yao)(yao)(yao)板(ban)(ban)块(kuai)自2019年起累计建(jian)设中(zhong)(zhong)(zhong)药(yao)(yao)(yao)材GACP基(ji)地200多个,覆(fu)盖80多个品种(zhong),种(zhong)植面(mian)积逾(yu)30万(wan)亩。另一方(fang)面(mian),加快中(zhong)(zhong)(zhong)药(yao)(yao)(yao)工业(ye)转型升(sheng)级(ji)。国(guo)药(yao)(yao)(yao)集团旗(qi)下的(de)(de)(de)一方(fang)制药(yao)(yao)(yao)、天江药(yao)(yao)(yao)业(ye)占国(guo)内中(zhong)(zhong)(zhong)药(yao)(yao)(yao)配方(fang)颗粒超过52%的(de)(de)(de)市场(chang)份额。中(zhong)(zhong)(zhong)药(yao)(yao)(yao)饮片板(ban)(ban)块(kuai)业(ye)务覆(fu)盖全(quan)国(guo)重点城市。中(zhong)(zhong)(zhong)成(cheng)药(yao)(yao)(yao)板(ban)(ban)块(kuai)整合了中(zhong)(zhong)(zhong)药(yao)(yao)(yao)控股和国(guo)药(yao)(yao)(yao)太极两大产(chan)品线,拥有包括藿(huo)香正气液、急支(zhi)糖浆、玉屏风化(hua)(hua)(hua)(hua)湿败(bai)毒颗粒等超过1500个成(cheng)药(yao)(yao)(yao)品规(gui)。国(guo)药(yao)(yao)(yao)集团还积极发展(zhan)中(zhong)(zhong)(zhong)医药(yao)(yao)(yao)健康服务业(ye),在多个省市落(luo)地国(guo)医馆,提(ti)(ti)供多元化(hua)(hua)(hua)(hua)中(zhong)(zhong)(zhong)医药(yao)(yao)(yao)健康服务。